GE Healthcare
 
GE Healthcare Life Sciences Part of GE Healthcare
Location: Home > BioProcess™ > Target Molecules > Recombinant Proteins > Yeast
BioProcess™
Target Molecules
Antibodies
Plasma Proteins
Recombinant Proteins
Bacteria
Insect Cells
Mammalian cells
Transgenics
Yeast
Vaccines

Yeast (e.g. S. cerevisiae, P. pastoris)

A yeast expression system may be a secretion system or an intracellular expression system. Expression levels are generally lower for secretion systems but purification may be facilitated since yeast normally secretes only a small proportion of its own proteins into the growth medium. In contrast to the bacterial expression systems, yeast express proteins with correct N-terminal amino acid residues.

Glycosylation in a yeast system is mainly restricted to the high-mannose oligosaccharide type which means that yeast cannot be considered if the thereapeutic protein contains more complex-type oligosaccharides that are required for biological activity or to prevent a fast clearance of the product from the body.

Even if yeast systems generally show lower expression levels than bacterial systems, there are examples of high-level production, one of the most used is the Pichia pastoris system which offers a cost-effective method for industrial fermentation. This system can produce up to 10 g of protein per litre.

Main validation issue in general is glycosylation pattern.

Advantages
  • Well known genetics
  • Rapid cell growth (doubles in ­ 90 min)
  • Inexpensive culture media
  • Secretion systems available
  • Provides and facilitates disulfide bond formation and glycosylation
  • Relatively few purification problems
Disadvantages
  • Heterologous proteins may be incorrectly glycosylated and folded
  • Overglycosylation is a risk
  • Other posttranslational modifications are limited
  • Generally lower expression levels than in bacterial systems
Read more about how to produce recombinant proteins with bacteria, insect cells, mamalian cells, and transgenics.